Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: As the new coronavirus spreads from China, travel guidelines being issued by governments across the world all express notes of growing caution. But they contain subtle differences on where to avoid, how to behave and what to do after a trip. With few exceptions, the prevailing advice of national authorities is to avoid Hubei province - epicenter of an outbreak that has now infected 80,000 people worldwide - and to reduce Chinese travel to the bare minimum. Once inside China, Swiss travelers for example are urged by their government to avoid large gatherings and "cough or sneeze into a tissue, or use the crook of your arm". France tells its nationals not to eat raw meat or visit animal markets. The Spanish Foreign Ministry also urges against contact with animals in China and suggests making sure that you stay at least one meter away from the next person. For travelers to Italy - the country most badly hit by the virus in Europe - the Dutch government recommends that its citizens avoid areas already locked down by local authorities and only travel to parts of the wider Lombardy region around the closed-off towns if necessary. The Finnish Foreign Ministry advice on Italy is simply to "take special care". Differences also emerge in the advice to travelers on their return from an affected area. Germany's main authority for infectious diseases tells those returning with symptoms from outbreak regions in Italy to see a doctor and call prior to their visit. But France asks such people not to visit the doctor but to call emergency services. Britain urges its nationals to "self-isolate" at home if they have been to the areas quarantined by Italy whether or not they have symptoms. The Danish Health Authority currently stipulates no routine quarantine or isolation of people who have traveled to China or other places hit by the outbreak. Countries outside Europe take different stances. Turkey advises against all but essential travel to China but has not yet issued travel advice on Italy. Nigeria has a voluntary two-week self-quarantine in place for all passengers arriving from China or any country with "a major outbreak". Guidance for returning air passengers says "try to avoid" going out but wear a mask if you do. Claim: Coronavirus travel: national advice not all of a piece.

A: Should travelers avoid parts of the world near coronavirus hotspots? Or go - but then tread carefully? The official advice they receive may depend on whether they live in Amsterdam, Helsinki, Madrid or Lagos.
****
Q: Paragraph: The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Teva said the money will come from a pre-existing fund that was created in 2015 as part of the company's settlement with the U.S. Federal Trade Commission over similar claims, and it will not make any additional payments. Becerra said such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. "No one in America should be forced to skip or ration doses of medicine that they need ... and certainly not because a drug company is colluding to keep the price of your drug artificially high even when cheaper options could be available. But that's what's happening," Becerra said. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Teva said it is paying $200,000 to cover the state's legal costs after settling similar federal claims earlier this year. Neither Endo nor Teikoku responded to requests for comment. Both settlements bar the companies from pay-for-delay agreements for several years. Teva is agreeing to not to enter any such agreements for 10 years, while Endo Pharmaceuticals has an eight-year agreement and Teikoku a 20-year injunction. Teva said the restriction is identical to its federal consent decree. Becerra also backed pending legislation, AB824 by Democratic Assemblyman Jim Wood of Santa Rosa, that would ban such agreements. The measure would require pharmaceutical companies to prove that their agreements are not anticompetitive. It passed the Assembly 56-0 in May and is awaiting a vote in the Senate. Pharmaceutical companies oppose the bill, arguing the Federal Trade Commission already does this monitoring. ___ This story has been corrected to say that while there are four settlement agreements, they involve only three companies. Claim: 3 companies pay California $70 million for delaying drugs.

A: Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday.
****
Q: Paragraph: The Rhode Island Department of Health and the state Department of Environmental Management earlier this week announced that seasonal cooling and declining daylight have signaled a great reduction in risk. However, officials said there's no guarantee the toxins are absent, warning that a warm spell could trigger an algae bloom during the winter or spring. While the seasonal monitoring of cyanobacteria in 2019 is complete, the public is reminded to avoid contact with any body of water that appears to be bright green or has a dense, floating mass on the surface. Blue-green algae blooms may also look like green paint or thick pea soup and the toxins may still persist in the water even if the bloom is no longer visible. Advisories have been lifted for Paradise Pond in Middletown, Sisson Pond in Portsmouth, Slack Reservoir in Smithfield-Johnston, Carbuncle Pond in Coventry, Almy Pond in Newport, Elm Lake in Providence, JL Curran Resevoir in Cranston, Mashapaug, Pleasure and Roosevelt ponds in Providence, and Melville Pond in Portsmouth. As of earlier this week, an advisory was still in place for Watson Reservoir in Little Compton, where there were still visual signs of a cyanobacteria bloom. People who come into contact with potentially affected waters should rinse their skin and wash their clothes with clean water as soon as possible. Meanwhile, people with pets that exhibit adverse health symptoms after coming in contact with potentially affected waters should contact their veterinarians. Claim: Rhode Island officials lift advisories for blue-green algae.

A:
Rhode Island health and environmental officials have lifted recreational advisories that have been in place for a number of bodies of water because of a blue-green algae known as cyanobacteria.
****